Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Currently, the system available is the MicraTM Transcatheter Pacing System. On November 2017, the worldwide implants of the NanostimTM Leadless Pacemaker System were halted. These devices have shown promising results in the various clinical trials with complications mostly due to the implant procedure. In order to avoid these complications, a correct learning curve of the operators has resulted very important. Recently, a new system, the WiSE-CRT, has been introduced as a leadless alternative to cardiac resynchronization therapy. While the results of randomized trials and long-term follow-up studies are still pending, in this paper we will review the main clinical data that have been published to date, comparing them to the traditional devices for transvenous endocardial stimulation.

[Leadless pacing: present and future of cardiac stimulation] / Piro, Agostino; Lavalle, Carlo; Della Rocca, Domenico G; Scarparo, Paola; Mancone, Massimo; Maestrini, Viviana; Di Biase, Luigi; Natale, Andrea; Fedele, Francesco. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1827-6806. - 20:1(2019), pp. 32-40. [10.1714/3079.30718]

[Leadless pacing: present and future of cardiac stimulation]

Piro, Agostino;Lavalle, Carlo
;
Scarparo, Paola;Mancone, Massimo;Maestrini, Viviana;Fedele, Francesco
2019

Abstract

Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Currently, the system available is the MicraTM Transcatheter Pacing System. On November 2017, the worldwide implants of the NanostimTM Leadless Pacemaker System were halted. These devices have shown promising results in the various clinical trials with complications mostly due to the implant procedure. In order to avoid these complications, a correct learning curve of the operators has resulted very important. Recently, a new system, the WiSE-CRT, has been introduced as a leadless alternative to cardiac resynchronization therapy. While the results of randomized trials and long-term follow-up studies are still pending, in this paper we will review the main clinical data that have been published to date, comparing them to the traditional devices for transvenous endocardial stimulation.
2019
bradyarrhythmias; cardiac arrhythmias; cardiac pacing; cardiac resynchronization therapy; leadless pacemaker; transvenous leads; transvenous pacemaker.
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
[Leadless pacing: present and future of cardiac stimulation] / Piro, Agostino; Lavalle, Carlo; Della Rocca, Domenico G; Scarparo, Paola; Mancone, Massimo; Maestrini, Viviana; Di Biase, Luigi; Natale, Andrea; Fedele, Francesco. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1827-6806. - 20:1(2019), pp. 32-40. [10.1714/3079.30718]
File allegati a questo prodotto
File Dimensione Formato  
Piro_Leadless _2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 415.1 kB
Formato Adobe PDF
415.1 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1301762
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact